Skip to main content

CHDI "Great Minds Think for Kids" Seminar Series

Thursday, February 27, 2020
Kaveh Ardalan, MD

The goal of the Children’s Health & Discovery initiative (CHDI) is to foster multidisciplinary and innovative research that will positively impact childhood and lifelong health. Efforts in four key research focus areas (genes and biology, physical environment, social and economic factors, and health and behavior needs) will inform prevention, risk screening, and treatment, as well as provide training opportunities for the next generation of pediatrician-scientists to learn from Duke’s cadre of experts. As part of our goal of fostering multidisciplinary collaborations, the CHDI is holding seminar/brainstorming sessions, which we’ve termed “Great Minds Think for Kids”, beginning this January. These sessions will include a 40-minute research-in-progress talk from a guest speaker, followed by a 40-minute brainstorming/group discussion session led by the guest speaker and a member of the CHDI scientific leadership.

Details about the March seminar/brainstorming session follow:

Date: March 17, 2020
Time: 12:00 pm to 1:00 pm
Location: MSRB III, Room 1125

Seminar Title: "Outcomes in Pediatric Rheumatic Diseases: Interplay of Mental Health, Physical Health, and Quality of Life"
Speaker: Kaveh Ardalan, MD, MS
Assistant Professor of Pediatrics
Division of Rheumatology

Dr. Ardalan completed medical school at University of Virginia, pediatric residency at New York University, pediatric rheumatology fellowship at Children's Hospital of Pittsburgh, and an MS Clinical Research at the University of Pittsburgh.  His early work in Pittsburgh included the first longitudinal analysis of predictors of health-related quality of life in juvenile localized scleroderma and mixed methods studies that supported development of a juvenile localized scleroderma-specific health-related quality of life instrument. After fellowship, he joined the faculty at Northwestern University Feinberg School of Medicine (Ann & Robert H. Lurie Children’s Hospital of Chicago), where he redirected his clinical and research focus to juvenile dermatomyositis (JDM) and cutaneous lupus patients, eventually becoming Clinical Director of the CureJM Center of Excellence in Juvenile Myositis Care and Research at Lurie Children’s. He co-leads the Childhood Arthritis & Rheumatology Research Alliance (CARRA) Lupus Dermatology workgroup and has been co-PI on an 18-site retrospective cohort study of pediatric discoid lupus outcomes. He conducted dermatomyositis epidemiologic studies, publishing the first national study of cardiovascular comorbidities in JDM. He has also validated PROMIS measures for assessing health-related quality of life in JDM and conducted focus groups on parent perceptions of mental health in JDM. In October 2019, he joined Duke University School of Medicine as co-director of Duke’s recently designated CureJM Center of Excellence in Juvenile Idiopathic Inflammatory Myopathies. He is currently developing proposals to study the psychobiology of stress and cardiovascular disease in juvenile lupus and dermatomyositis.

If you have questions or need additional information, please contact Carter Crew at carter.crew@duke.edu.


Learn more about the CHDI